Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
Leukocare AG logo — Experts in Sterile Drug Product Development Services

Leukocare AG

Experts in Sterile Drug Product Development Services

Founded 2003 Germany Planegg, Germany 46 employees Debt Financing Total: $17.50M AI, Biotechnology +2

General Information

Company Name Leukocare AG
Founded Year 2003
Location Germany Planegg, Germany
Employees 46
Industries AI, Biotechnology, Health Care +1
Funding Stage Debt Financing
Social

BounceWatch is an independent company data service, not affiliated with Leukocare AG. To contact Leukocare AG, visit leukocare.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Leukocare AG compare?

A PDF of Leukocare AG and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Leukocare AG soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Leukocare AG

Leukocare AG is a biotechnology company, based in Germany and founded in 2003. The company is an innovator in drug product development for biologics, focusing on tailored services to enhance the stability and formulation of drug products, thus extending shelf life and streamlining logistics, thereby mitigating risks in drug development programs. What sets Leukocare apart from others is its utilization of bioinformatics and biostatistics-based approaches in the Design of Experiment (DoE) to explore a wider design space for identifying the optimal combination of excipients. This unique approach synergizes in-silico methods with wet lab experiments, ultimately reducing the number of experiments required and the need for high throughput. Furthermore, this also results in reduced usage of drug substance and accelerated development time. The company's database of over 100+ regulatory approved excipients contributes to reducing obstacles in later clinical stages. In addition to formulation development, Leukocare offers analytical and bioinformatics services for ongoing drug discovery and development projects, demonstrating strong expertise in particle characterization, stability analysis, and molecular integrity assessment, among others. The latest investment in Leukocare AG was a $2.50M Venture Round investment on 23 June 2021, led by Petrichor Healthcare. This investment is anticipated to further propel the company's innovative approach in providing specialized drug product development services for biologics.

Business keywords: biopharmaceutical formulation development, drug product development, bioinformatics, biostatistics, formulation development, analytical services, in-silico methods, excipients, regulatory approved, particle characterization, molecular integrity analysis, stability prediction, Lyo optimization, viral vectors

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round $2.50M 1
Petrichor Healthcare Capital Management
23 Jun 2021
Debt Financing $15.00M 1
Petrichor Healthcare Capital Management
23 Jun 2021
Venture Round Undisclosed 1
LifeCare Partners
22 Jul 2015

Leukocare AG Alternatives & Competitors

View All Alternatives
Leukocare AG vs
KABS Laboratories Inc.
KABS Laboratories Inc. Canada

One product: Commitment.

91 employees
Biotechnology, Health Care
Compare Leukocare AG vs KABS Laboratories Inc.
Leukocare AG vs
LiVeritas Biosciences, Inc.
LiVeritas Biosciences, Inc. United States

Pioneering Agentic AI for Regulated Science

11 employees
AI, Biopharma
Compare Leukocare AG vs LiVeritas Biosciences, Inc.
Leukocare AG vs
Comera Life Sciences
Comera Life Sciences United States

Comera Life Sciences transforms the formulation of biotherapeutics for the ultimate benefit of patie...

Post-IPO Equity
2 employees
Biotechnology, Health Care
View all alternatives

FAQ About Leukocare AG

Experts in Sterile Drug Product Development Services
Leukocare AG was founded in 2003.
Leukocare AG is headquartered in Planegg, Germany.
Leukocare AG operates in AI, Biotechnology, Health Care and Medical Devices. Its work centres on biopharmaceutical formulation development, drug product development, bioinformatics and biostatistics.
Leukocare AG has approximately 46 employees.
Leukocare AG has completed 3 funding rounds, raising a total of $17.50M. The latest funding stage is Debt Financing.
Top alternatives and competitors to Leukocare AG include KABS Laboratories Inc., LiVeritas Biosciences, Inc., Comera Life Sciences, Berkshire Sterile Manufacturing, In Vitro Diagnostic Solutions (IVDS). These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Leukocare AG and KABS Laboratories Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Leukocare AG, https://bouncewatch.com/company/leukocare-ag, updated 30 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes